EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

European Society for Pediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) steatotic liver disease special interest group position paper on screening, diagnosis and investigation of paediatric metabolic dysfunction‐associated steatotic liver disease

Jake P Mann iD, Sander Lefere, Maarten Buytaert, Anna Alisi, Cigdem Arikan, Jernej Brecelj, Rachel M Brown, Irene Degrassi, Giulia Fiore, Emer Fitzpatrick, Sven Francque, Christian A Hudert und 19 weitere

Journal of Pediatric Gastroenterology and Nutrition · 2026-09 · 83 (3) · 555-576

DOI: 10.1002/jpn3.70490 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pediatric Gastroenterology and Nutrition, online erschienen am 30.06.2026. Verfasst von Jake P Mann und 30 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology & Immunotherapy, School of Infection, Inflammation and Immunology, College of Medicine and Health, University of Birmingham,…. Hauptthemen laut MEDLINE: Fatty Liver, Metabolic Diseases. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 218 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: FWO Flanders, Birmingham NIHR Biomedical Research Centre, Royal Society.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metabolic dysfunction‐associated steatotic liver disease (MASLD) is the most common reason for elevated liver enzymes in children in Europe, affecting more than 5% of all children. Since the last iteration of this position paper, there have been substantial advances in our understanding of the disease. After a detailed literature review and thorough discussion, we established consensus recommendations for the diagnosis and assessment of MASLD in children. Alanine aminotransferase (ALT) ≥ 30 IU/L is a suitable screening test for MASLD in children over 10 years of age with obesity (body mass index z ‐score ≥+2), or in children of any age with additional risk factors. All patients with suspected MASLD should be assessed for alternative or concomitant diagnoses, as well as comorbidities. Patients who are not overweight, under 8 years old, or have any other red flags should be promptly referred for specialist assessment. Liver biopsy remains the gold standard for diagnosis and staging of MASLD, but should be reserved for diagnostic uncertainty, to guide treatment decisions, and risk stratification (e.g., prior to transition to adult care). While there is emerging data for non‐invasive tests (e.g., transient elastography), it is unclear how to routinely implement these investigations in clinical practice. Combined changes of ≥20% in both ALT and gamma‐glutamyl transferase may represent a useful non‐invasive tool for monitoring disease severity over time. Most patients are appropriately investigated and managed by non‐specialists where the focus is on holistic management of obesity and its complications. Future research should focus on how to use non‐invasive tests to risk‐stratify children, in particular, how to identify those with advanced fibrosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fatty LiverMetabolic DiseasesChildHumansAlanine TransaminaseBiopsyEuropeGastroenterologyLiverMass ScreeningRisk Factors

Stichwörter der Autor:innen

diabeteselastographyliver biopsyobesitysteatohepatitis

Substanzen

Alanine Transaminase

Autor:innen und Institutionen

  • Department of Immunology & Immunotherapy, School of Infection, Inflammation and Immunology, College of Medicine and Health, University of Birmingham, Birmingham, UK.
  • Liver Unit (Including Small Bowel Transplantation), Birmingham Women's and Children's NHS Foundation Trust, Birmingham, UK.
  • Hepatology Research Unit, Department of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium.
  • Genetic of Complex Phenotype Research Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
  • Department of Pediatric Gastroenterology and Organ Transplant, Koç University School of Medicine, Istanbul, Turkey.
  • Department of Gastroenterology, Hepatology and Nutrition, University Children's Hospital Ljubljana, and Department of Pediatrics, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.

ORCID-Profile: Jake P Mann

Förderung

  • FWO Flanders
  • Birmingham NIHR Biomedical Research Centre
  • Royal Society
  • Guts UK Charity
  • ESPGHAN
  • Royal College of Physicians
  • Little Princess Trust

Zitieren

APA

Mann, J. P., Lefere, S., Buytaert, M., Alisi, A., Arikan, C., Brecelj, J., Brown, R. M., Degrassi, I., Fiore, G., Fitzpatrick, E., Francque, S., Hudert, C. A., Janczyk, W., Johansen, L., Koot, B. G., Konidari, A., Lurz, E., Mandato, C., Mercadal-Hally, M., …, & Bruyne, R. (2026). European Society for Pediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) steatotic liver disease special interest group position paper on screening, diagnosis and investigation of paediatric metabolic dysfunction‐associated steatotic liver disease. Journal of Pediatric Gastroenterology and Nutrition, 83(3), 555-576. https://doi.org/10.1002/jpn3.70490

Vancouver

Mann JP, Lefere S, Buytaert M, Alisi A, Arikan C, Brecelj J, et al. European Society for Pediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) steatotic liver disease special interest group position paper on screening, diagnosis and investigation of paediatric metabolic dysfunction‐associated steatotic liver disease. Journal of Pediatric Gastroenterology and Nutrition. 2026;83(3):555-576. doi:10.1002/jpn3.70490

BibTeX
@article{Mann2026,
  author = {Mann, Jake P and Lefere, Sander and Buytaert, Maarten and Alisi, Anna and Arikan, Cigdem and Brecelj, Jernej and Brown, Rachel M and Degrassi, Irene and Fiore, Giulia and Fitzpatrick, Emer and Francque, Sven and Hudert, Christian A and Janczyk, Wojciech and Johansen, Lauren and Koot, Bart G and Konidari, Anastasia and Lurz, Eberhard and Mandato, Claudia and Mercadal-Hally, Maria and Moran-Lev, Hadar and Mosca, Antonella and Ranucci, Giusy and Rogalidou, Maria and Rose, Penelope C and Socha, Piotr and Vajro, Pietro and Verduci, Elvira and Vreugdenhil, Anita C E and Zavhorodnia, Natalia and Zellos, Aglaia and Bruyne, Ruth De},
  title = {European Society for Pediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) steatotic liver disease special interest group position paper on screening, diagnosis and investigation of paediatric metabolic dysfunction‐associated steatotic liver disease},
  journal = {Journal of Pediatric Gastroenterology and Nutrition},
  year = {2026},
  volume = {83},
  number = {3},
  pages = {555--576},
  doi = {10.1002/jpn3.70490}
}
Kostenlos starten →